MedPath

APO-BILASTINE ORAL SOLUTION

APO-BILASTINE ORAL SOLUTION

Approved
DIN Number

02549867

Drug Class

Human

Market Date

N/A

Company
HC

Apotex Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02549867
AIG Number0158051002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R06AX OTHER ANTIHISTAMINES FOR SYSTEMIC USE
Product Specifications
Dosage FormSolution
Route of AdministrationOral
AHFS Classification04:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

BILASTINEActive
Strength: 2.5 MG / ML
Monograph: BILASTINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.